This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Shohei Inoue: Innovator in Water-Soluble Drug Preparations
Introduction
Shohei Inoue is a notable inventor based in Japan, recognized for his contributions to the field of pharmaceutical innovations. His work primarily focuses on the development of water-soluble high molecular polymerized drugs, which have significant implications for drug delivery systems.
Latest Patents
Inoue's most prominent invention is a water-soluble high molecular polymerized drug preparation. This invention comprises a water-soluble block copolymer that includes a hydrophilic segment and a hydrophobic pharmacological-functioning segment to which a drug is bonded. The hydrophilic segment can include materials such as polyethylene glycol, polysaccharides, and polyacrylamide. The hydrophobic segment, which is attached to the drug, may consist of polyaspartic acid, polyglutamic acid, polylysine, or their derivatives. The drugs that can be attached to the hydrophobic segment include anti-cancer drugs, drugs for central and peripheral nerves, and drugs for circulatory organs. Despite his innovative work, Inoue currently holds 0 patents.
Career Highlights
Throughout his career, Shohei Inoue has made significant strides in the pharmaceutical industry. His research and development efforts have focused on enhancing drug solubility and efficacy, which are critical for improving patient outcomes.
Collaborations
Inoue has collaborated with several prominent figures in the field, including Yasuhisa Sakurai and Kazunori Kataoka. These collaborations have allowed him to leverage diverse expertise and advance his research initiatives.
Conclusion
Shohei Inoue's work in developing water-soluble high molecular polymerized drugs represents a significant advancement in pharmaceutical technology. His innovative approach has the potential to improve drug delivery systems and enhance therapeutic efficacy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile